IL193295A0 - Piperidine derivatives as cxcr3 receptor antagonists - Google Patents
Piperidine derivatives as cxcr3 receptor antagonistsInfo
- Publication number
- IL193295A0 IL193295A0 IL193295A IL19329508A IL193295A0 IL 193295 A0 IL193295 A0 IL 193295A0 IL 193295 A IL193295 A IL 193295A IL 19329508 A IL19329508 A IL 19329508A IL 193295 A0 IL193295 A0 IL 193295A0
- Authority
- IL
- Israel
- Prior art keywords
- receptor antagonists
- piperidine derivatives
- cxcr3 receptor
- cxcr3
- piperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06101551 | 2006-02-10 | ||
PCT/EP2007/051123 WO2007090836A2 (en) | 2006-02-10 | 2007-02-06 | Piperidine derivatives as cxcr3 receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
IL193295A0 true IL193295A0 (en) | 2009-08-03 |
Family
ID=35911097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL193295A IL193295A0 (en) | 2006-02-10 | 2008-08-07 | Piperidine derivatives as cxcr3 receptor antagonists |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1983986A2 (ko) |
JP (1) | JP2009526016A (ko) |
KR (1) | KR20080093040A (ko) |
CN (1) | CN101378756A (ko) |
AR (1) | AR059427A1 (ko) |
AU (1) | AU2007213744A1 (ko) |
BR (1) | BRPI0707629A2 (ko) |
CA (1) | CA2635138A1 (ko) |
EA (1) | EA200870246A1 (ko) |
IL (1) | IL193295A0 (ko) |
NO (1) | NO20083856L (ko) |
TW (1) | TW200811131A (ko) |
WO (1) | WO2007090836A2 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2852160A1 (en) | 2011-10-28 | 2013-05-02 | Galderma Research & Development | New leukocyte infiltrate markers for rosacea and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE632403A (ko) * | 1962-05-17 | 1900-01-01 | ||
DE60209736T2 (de) * | 2001-07-02 | 2006-11-02 | Astrazeneca Ab | Piperidinverbindungen, die sich als modulatoren der chemokinrezeptoraktivität eignen |
-
2007
- 2007-02-06 CA CA002635138A patent/CA2635138A1/en not_active Abandoned
- 2007-02-06 EA EA200870246A patent/EA200870246A1/ru unknown
- 2007-02-06 CN CNA2007800049228A patent/CN101378756A/zh active Pending
- 2007-02-06 EP EP07726319A patent/EP1983986A2/en not_active Withdrawn
- 2007-02-06 WO PCT/EP2007/051123 patent/WO2007090836A2/en active Application Filing
- 2007-02-06 AU AU2007213744A patent/AU2007213744A1/en not_active Abandoned
- 2007-02-06 JP JP2008553749A patent/JP2009526016A/ja not_active Withdrawn
- 2007-02-06 BR BRPI0707629-0A patent/BRPI0707629A2/pt not_active Application Discontinuation
- 2007-02-06 KR KR1020087019298A patent/KR20080093040A/ko not_active Application Discontinuation
- 2007-02-09 TW TW096104683A patent/TW200811131A/zh unknown
- 2007-02-09 AR ARP070100558A patent/AR059427A1/es unknown
-
2008
- 2008-08-07 IL IL193295A patent/IL193295A0/en unknown
- 2008-09-08 NO NO20083856A patent/NO20083856L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1983986A2 (en) | 2008-10-29 |
CA2635138A1 (en) | 2007-08-16 |
CN101378756A (zh) | 2009-03-04 |
AU2007213744A1 (en) | 2007-08-16 |
TW200811131A (en) | 2008-03-01 |
AR059427A1 (es) | 2008-04-09 |
KR20080093040A (ko) | 2008-10-17 |
EA200870246A1 (ru) | 2009-02-27 |
WO2007090836A2 (en) | 2007-08-16 |
BRPI0707629A2 (pt) | 2011-05-10 |
JP2009526016A (ja) | 2009-07-16 |
WO2007090836A3 (en) | 2007-11-29 |
NO20083856L (no) | 2008-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL202665A0 (en) | Piperidine derivatives useful as orexin receptor antagonists | |
IL205665A0 (en) | Heteroaryl derivatives as orexin receptor antagonists | |
IL201112A0 (en) | Thiazolidine derivatives as orexin receptor antagonists | |
HRP20151108T1 (en) | Nogo receptor antagonists | |
EP2099454A4 (en) | AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR ANTAGONISTS | |
ZA200800320B (en) | Indol-3-carbonyl-spiro-piperidine derivatives as Via receptor antagonists | |
IL213345A0 (en) | Piperidine derivatives useful as orexin antagonists | |
EP2120573A4 (en) | DERIVATIVES OF PIPERIDINE | |
EP2058304A4 (en) | P2X4 RECEPTOR ANTAGONIST | |
AP1983A (en) | Carboxamide derivatives as muscarinic receptor antagonists | |
ZA200902187B (en) | 8-Ethinylxanthine derivatives as selective A2A receptor antagonists | |
IL196587A0 (en) | 2-phenyl-indoles as prostaglandin d2 receptor antagonists | |
IL196734A0 (en) | Piperidine derivatives | |
IL192308A0 (en) | Oxazoloisoquinoline derivatives as thrombin receptor antagonists | |
AU2008281876A8 (en) | Monoamide derivatives as orexin receptor antagonists | |
IL213982A0 (en) | Piperidine derivatives as nk3 receptor antagonists | |
PL1912976T3 (pl) | Pochodne indol-3-ilokarbonylopiperydynobenzoimidazolu jako antagoniści receptora V1a | |
IL205949A0 (en) | 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists | |
HK1135110A1 (en) | Nk1 receptor antagonist composition nk1 | |
EP2365748A4 (en) | IMIDAZOISOINDOLA ANTAGONISTS OF NEUROPEPTIDE S RECEPTORS | |
EP1898905A4 (en) | ANTAGONISTS OF TACHYKININ HYDRO-ISO-INDOLIC RECEPTORS | |
ZA200802339B (en) | Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists | |
ZA200903499B (en) | Indoles which act as via receptor antagonists | |
ZA200903496B (en) | Spiro-piperidine derivatives as via receptor antagonists | |
IL193294A0 (en) | Piperidine derivatives as cxcr3 receptor antagonists |